ProfessorDepartment of Pediatric Hematology, Istanbul University Oncology Institute, Inherited Bleeding Disorders Center, Istanbul, TurkeyIstanbul, Istanbul, Turkey
OC 50.2 - Long-term outcomes with efanesoctocog alfa prophylaxis for previously treated children with severe hemophilia A, an interim analysis of the phase 3 XTEND-ed study
Tuesday, June 25, 202409:45 – 10:00 ICT